552 related articles for article (PubMed ID: 22411637)
21. Hydroxypropyl-β-cyclodextrin copolymers and their nanoparticles as doxorubicin delivery system.
Wang T; Zhang C; Liang XJ; Liang W; Wu Y
J Pharm Sci; 2011 Mar; 100(3):1067-79. PubMed ID: 20922814
[TBL] [Abstract][Full Text] [Related]
22. Effects of surfactants on the properties of PLGA nanoparticles.
Menon JU; Kona S; Wadajkar AS; Desai F; Vadla A; Nguyen KT
J Biomed Mater Res A; 2012 Aug; 100(8):1998-2005. PubMed ID: 22566409
[TBL] [Abstract][Full Text] [Related]
23. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
24. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
Liu SQ; Tong YW; Yang YY
Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
[TBL] [Abstract][Full Text] [Related]
25. Doxorubicin-loaded poly (lactic-co-glycolic acid) nanoparticles coated with chitosan/alginate by layer by layer technology for antitumor applications.
Chai F; Sun L; He X; Li J; Liu Y; Xiong F; Ge L; Webster TJ; Zheng C
Int J Nanomedicine; 2017; 12():1791-1802. PubMed ID: 28424550
[TBL] [Abstract][Full Text] [Related]
26. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
Liu P; Yu H; Sun Y; Zhu M; Duan Y
Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
[TBL] [Abstract][Full Text] [Related]
27. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
28. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
29. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
[TBL] [Abstract][Full Text] [Related]
30. Doxorubicin-loaded nanosized micelles of a star-shaped poly(ε-caprolactone)-polyphosphoester block co-polymer for treatment of human breast cancer.
Cuong NV; Hsieh MF; Chen YT; Liau I
J Biomater Sci Polym Ed; 2011; 22(11):1409-26. PubMed ID: 20594418
[TBL] [Abstract][Full Text] [Related]
31. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes.
Upadhyay KK; Bhatt AN; Mishra AK; Dwarakanath BS; Jain S; Schatz C; Le Meins JF; Farooque A; Chandraiah G; Jain AK; Misra A; Lecommandoux S
Biomaterials; 2010 Apr; 31(10):2882-92. PubMed ID: 20053435
[TBL] [Abstract][Full Text] [Related]
32. pH-triggered intracellular release from actively targeting polymer micelles.
Guo X; Shi C; Wang J; Di S; Zhou S
Biomaterials; 2013 Jun; 34(18):4544-54. PubMed ID: 23510854
[TBL] [Abstract][Full Text] [Related]
33. Biamphiphilic triblock copolymer micelles as a multifunctional platform for anticancer drug delivery.
Zhu W; Li Y; Liu L; Zhang W; Chen Y; Xi F
J Biomed Mater Res A; 2011 Feb; 96(2):330-40. PubMed ID: 21171152
[TBL] [Abstract][Full Text] [Related]
34. Chitosan/PLA nanoparticles as a novel carrier for the delivery of anthraquinone: synthesis, characterization and in vitro cytotoxicity evaluation.
Jeevitha D; Amarnath K
Colloids Surf B Biointerfaces; 2013 Jan; 101():126-34. PubMed ID: 22796782
[TBL] [Abstract][Full Text] [Related]
35. Enhanced anti-topoisomerase II activity by mucoadhesive 4-CBS-chitosan/poly (lactic acid) nanoparticles.
Songsurang K; Suvannasara P; Phurat C; Puthong S; Siraleartmukul K; Muangsin N
Carbohydr Polym; 2013 Nov; 98(2):1335-42. PubMed ID: 24053811
[TBL] [Abstract][Full Text] [Related]
36. Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells.
Shieh MJ; Hsu CY; Huang LY; Chen HY; Huang FH; Lai PS
J Control Release; 2011 Jun; 152(3):418-25. PubMed ID: 21435362
[TBL] [Abstract][Full Text] [Related]
37. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
[TBL] [Abstract][Full Text] [Related]
38. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
[TBL] [Abstract][Full Text] [Related]
39. Lysine-tagged peptide coupling onto polylactide nanoparticles coated with activated ester-based amphiphilic copolymer: a route to highly peptide-functionalized biodegradable carriers.
Handké N; Ficheux D; Rollet M; Delair T; Mabrouk K; Bertin D; Gigmes D; Verrier B; Trimaille T
Colloids Surf B Biointerfaces; 2013 Mar; 103():298-303. PubMed ID: 23277324
[TBL] [Abstract][Full Text] [Related]
40. Multi-morphological biodegradable PLGE nanoparticles and their drug release behavior.
Zhang H; Bei J; Wang S
Biomaterials; 2009 Jan; 30(1):100-7. PubMed ID: 18848724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
